Logo image of KVUE

KENVUE INC (KVUE) Stock News

NYSE:KVUE - New York Stock Exchange, Inc. - US49177J1025 - Common Stock

20.8  -0.3 (-1.42%)

Premarket: 20.89 +0.09 (+0.43%)

KVUE Latest News and Analysis

News Image
5 days ago - The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.

News Image
5 days ago - Benzinga

Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company

Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.

News Image
2 months ago - Yahoo Finance

Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.

These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.

News Image
2 months ago - Market News Video

Notable Tuesday Option Activity: ZI, KVUE, ETR

News Image
3 months ago - Market News Video

Interesting KVUE Call Options For December 6th

News Image
3 months ago - Investor's Business Daily

Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises

The activist investor says Pfizer has underperformed its peers and the broader market since 2019.

News Image
3 months ago - Investor's Business Daily

Nvidia Among Five Best S&P 500 Stocks Today

Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia was close behind.

News Image
3 months ago - Investor's Business Daily

Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies

Elf Beauty appeared to rally along with KVUE on Monday.

News Image
3 months ago - Yahoo Finance

Kenvue stock rises after activist Starboard Value takes 'sizable' stake: WSJ

(Bloomberg) -- Shares of consumer-products company Kenvue Inc. rose the most in two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to boost the company’s stock price.Most Read from BloombergA Broken Oil Pipeline Plunges South Sudan’s Capital Into ChaosDrug Decriminalization Spawns a Political Debacle for ProgressivesClimate Change Is Killing Buildings in Slow MotionCities Look to AI to Flag Residents’ Trash and Recycling Mistake